Pekarsky Y - Search Results

1

Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia.

Pekarsky Y, Rynditch A, Wieser R, Fonatsch C, Gardiner K. Pekarsky Y, et al. Cancer Res. 1997 Sep 15;57(18):3914-9. Cancer Res. 1997. PMID: 9307271

2

Cloning of breakpoints in 3q21 associated with hematologic malignancy.

Pekarsky Y, Zabarovsky E, Kashuba V, Drabkin H, Sandberg AA, Morgan R, Rynditch A, Gardiner K. Pekarsky Y, et al. Cancer Genet Cytogenet. 1995 Mar;80(1):1-8. doi: 10.1016/0165-4608(94)00168-b. Cancer Genet Cytogenet. 1995. PMID: 7697625

3

Leukemia breakpoint region in 3q21 is gene rich.

Rynditch A, Pekarsky Y, Schnittger S, Gardiner K. Rynditch A, et al. Among authors: pekarsky y. Gene. 1997 Jul 1;193(1):49-57. doi: 10.1016/s0378-1119(97)00076-0. Gene. 1997. PMID: 9249066

4

YAC clones targeting gene-rich regions of human chromosome 3.

Williams RF, Pekarsky Y, Cheng S, Gardiner K. Williams RF, et al. Among authors: pekarsky y. Mamm Genome. 1994 Jun;5(6):380-3. doi: 10.1007/BF00356559. Mamm Genome. 1994. PMID: 8043955 No abstract available.

5

The human myosin light chain kinase (MLCK) from hippocampus: cloning, sequencing, expression, and localization to 3qcen-q21.

Potier MC, Chelot E, Pekarsky Y, Gardiner K, Rossier J, Turnell WG. Potier MC, et al. Among authors: pekarsky y. Genomics. 1995 Oct 10;29(3):562-70. doi: 10.1006/geno.1995.9965. Genomics. 1995. PMID: 8575746

6

Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.

Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM. Bullrich F, et al. Among authors: pekarsky y. Cancer Res. 2001 Sep 15;61(18):6640-8. Cancer Res. 2001. PMID: 11559527

7

The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.

Pekarsky Y, Druck T, Cotticelli MG, Ohta M, Shou J, Mendrola J, Montgomery JC, Buchberg AM, Siracusa LD, Manenti G, Fong LY, Dragani TA, Croce CM, Huebner K. Pekarsky Y, et al. Cancer Res. 1998 Aug 1;58(15):3401-8. Cancer Res. 1998. PMID: 9699672

8

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.

Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CM. Pekarsky Y, et al. Cancer Res. 2006 Dec 15;66(24):11590-3. doi: 10.1158/0008-5472.CAN-06-3613. Cancer Res. 2006. PMID: 17178851

9

Tal1 transgenic expression reveals absence of B lymphocytes.

Palamarchuk A, Zanesi N, Aqeilan RI, Efanov A, Maximov V, Santanam U, Hagan JP, Croce CM, Pekarsky Y. Palamarchuk A, et al. Among authors: pekarsky y. Cancer Res. 2006 Jun 15;66(12):6014-7. doi: 10.1158/0008-5472.CAN-06-0937. Cancer Res. 2006. PMID: 16778172

10

Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.

Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y. Palamarchuk A, et al. Among authors: pekarsky y. Cancer Res. 2005 Jun 1;65(11):4515-9. doi: 10.1158/0008-5472.CAN-05-0751. Cancer Res. 2005. PMID: 15930267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page